Brociek Emil, Tymińska Agata, Giordani Andrea Silvio, Caforio Alida Linda Patrizia, Wojnicz Romuald, Grabowski Marcin, Ozierański Krzysztof
First Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Cardiology, Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, 35-100 Padova, Italy.
Biology (Basel). 2023 Jun 17;12(6):874. doi: 10.3390/biology12060874.
Myocarditis is an inflammatory disease of the myocardium caused by infectious or non-infectious agents. It can lead to serious short-term and long-term sequalae, such as sudden cardiac death or dilated cardiomyopathy. Due to its heterogenous clinical presentation and disease course, challenging diagnosis and limited evidence for prognostic stratification, myocarditis poses a great challenge to clinicians. As it stands, the pathogenesis and etiology of myocarditis is only partially understood. Moreover, the impact of certain clinical features on risk assessment, patient outcomes and treatment options is not entirely clear. Such data, however, are essential in order to personalize patient care and implement novel therapeutic strategies. In this review, we discuss the possible etiologies of myocarditis, outline the key processes governing its pathogenesis and summarize best available evidence regarding patient outcomes and state-of-the-art therapeutic approaches.
心肌炎是一种由感染性或非感染性因素引起的心肌炎症性疾病。它可导致严重的短期和长期后遗症,如心源性猝死或扩张型心肌病。由于其临床表现和病程的异质性、诊断具有挑战性以及预后分层的证据有限,心肌炎给临床医生带来了巨大挑战。目前,心肌炎的发病机制和病因仅得到部分了解。此外,某些临床特征对风险评估、患者预后和治疗选择的影响尚不完全清楚。然而,这些数据对于实现个性化患者护理和实施新的治疗策略至关重要。在本综述中,我们讨论了心肌炎可能的病因,概述了其发病机制的关键过程,并总结了关于患者预后和最新治疗方法的最佳现有证据。